Clinical trial
Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and…
NCT00183222 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00183222 |
|---|---|
| Title | Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking |
| Official title | Alcohol Research Center Grant. Component #1. COMBINING MEDICATIONS: ALCOHOL REACTIVITY AND CONSUMPTION |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol Dependence |
| Intervention type | Drug |
| Interventions | naltrexone (up to 50 mg/day) for 8 days, ondansetron (0.25 mg twice a day) for 8 days |
| Enrollment | 160 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | May 5, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: